握力是系统性坏死性血管炎的共病标志物并预测骨折和严重不良事件风险
23%患者握力低,但无人骨骼肌质量指数低。中位随访42个月,低握力与骨折风险(HR 4.25)和严重不良事件风险(HR 2.80)升高相关。
要点
- 系统性坏死性血管炎患者中低握力占23%,但骨骼肌质量指数均不低。
- 低握力与年龄、血管炎类型、损伤指数、跌倒史、骨质疏松、低白蛋白、高CRP、高FRAX及低股骨颈骨密度相关。
- 低握力预测随访期间骨折和严重不良事件风险升高。
核心结论
- 握力在系统性坏死性血管炎中与营养状态和骨病等共病相关,并似乎可预测随访期间骨折和严重不良事件风险。
- 相比之下,该人群中骨骼肌质量指数的评估仍不确定。
研究设计与样本
- 入组时用DXA评估骨骼肌质量指数、用握力评估肌力,记录血管炎和治疗相关事件并用Cox模型分析。
主要发现
- 入组时28例(23%)患者握力低(男性<30 kg、女性<20 kg),无患者骨骼肌质量指数低(男性<7.23 kg/m2、女性<5.67 kg/m2)。
- 低握力与年龄(P<0.0001)、血管炎类型(P=0.01)、血管炎损伤指数(P=0.01)、跌倒史(P=0.0002)、骨质疏松(P=0.04)、低血清白蛋白(P=0.003)和预白蛋白(P=0.0007)、高CRP(P=0.001)、高FRAX®工具(P=0.002)及低股骨颈骨密度(P=0.0002)相关。
- 中位随访42个月后,低握力与更高的骨折风险[HR 4.25(1.37-13.2),P=0.01]和严重不良事件风险[HR 2.80(1.35-5.81),P=0.006]相关。
临床怎么用
- 在系统性坏死性血管炎患者中可考虑用握力评估共病和预后风险。
- 低握力患者可能需关注骨折和严重不良事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sarcopenia has been associated with poor outcomes in various medical and surgical conditions. However, its impact in systemic necrotizing vasculitides (SNV) had never been characterized. We aimed to assess the prevalence, associated factors and prognostic impact of sarcopenia in SNV. METHODS: Patients with SNV were successively included in a prospective longitudinal study assessing comorbidities. At inclusion, we evaluated sarcopenia by assessing skeletal muscle mass index using DXA and muscle strength using handgrip strength. Vasculitis and treatments-related events were recorded and analysed using Cox models. RESULTS: One hundred and twenty patients were included. At inclusion, low handgrip strength (<30 kg for men and 20 kg for women) was identified in 28 (23%) patients, while no patient exhibited low skeletal muscle mass index (<7.23 kg/m2 for men and 5.67 kg/m2 for women). Low handgrip strength was associated with age (P <0.0001), type of vasculitis (P =0.01), vasculitis damage index (P =0.01), history of falls (P =0.0002), osteoporosis (P =0.04), low serum albumin (P =0.003) and prealbumin (P =0.0007), high CRP (P =0.001), high FRAX® tool (P =0.002) and low bone mineral density at femoral neck (P =0.0002). After median follow-up of 42 months, low handgrip strength was associated with higher risk of bone fracture [HR 4.25 (1.37-13.2), P =0.01] and serious adverse events [HR 2.80 (1.35-5.81), P =0.006]. CONCLUSION: Handgrip strength is associated in SNV with nutritional status and comorbidities such as bone disease, and seems to predict, as in other medical conditions, the risk of fracture and serious adverse events during follow-up. In contrast, assessment of skeletal muscle mass index in this population remains uncertain.
引用
- Henriquez S, Dunogué B, Porcher R, et al. Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events. Rheumatology (Oxford). 2020. PMID: 32449923. doi:10.1093/rheumatology/kez680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。